Sponsored
Chronic spontaneous urticaria: an overview
Chronic spontaneous urticaria (CSU) is an unpredictable debilitating skin condition that can significantly impact a patient’s quality of life. This article outlines how to recognise CSU, current evidence-based pharmacological management, …
Supporting informed decisions in pharmacy practice
Pharmacists make decisions every day that can affect a patient’s health. Checking a dose, identifying an interaction, explaining an adverse effect or clarifying a prescription calls for reliable information and …
What does allergic rhinitis relief mean for everyday life?
A runny nose, sneezing and itchy, watery eyes may be the obvious signs of allergic rhinitis (AR), but the impact can reach much further. AR can disrupt sleep and daily …
New study adds to the evidence base for S3 celecoxib
A new systematic review and meta-analysis published in Drugs addresses an evidence gap for S3 celecoxib, helping pharmacists to manage acute pain.1 Pharmacists are ideally placed to support the short-term …
Professional development and luxury travel: PSA Offshore 2027
Join industry colleagues for the 51st PSA Offshore Refresher Conference, set against the stunning backdrop of Eastern Europe and the Adriatic Coast from 5-13 May 2027. Over eight nights, the …
New Cyventine for smoking cessation
Cyventineâ„¢ (cytisine) is a new OTC way to help people (aged 18-65 years) quit smoking in 25 days.1 Cyventine is similar to varenicline, they are both partial agonists of the …
The first new smoking cessation aid registered in almost 20 years: a pharmacist’s guide to cytisine
George Krassas, Director and Medical Writer, Scius Healthcare Solutions Reviewed by Dr Brett MacFarlane Cytisine (Cyventineâ„¢) is the first new chemical entity registered in Australia to help people quit smoking …
Management of moderate–severe allergic rhinitis
Pharmacists can improve moderate–severe allergic rhinitis management by assessing symptom severity, matching treatment including dual therapy to patient needs, and reinforcing correct nasal spray technique. Shalini Jai Kumar BPharm (Hons), …
Cystic fibrosis management: an update on CFTR modulator therapy
CFTR modulator therapies have transformed cystic fibrosis care by improving the function of defective CFTR protein in people with responsive CFTR variants. Pharmacists should support safe and effective use of …
Allergic rhinitis relief starts with the right questions
Allergic rhinitis (AR) is often underdiagnosed and undermanaged.1,2 When patients present with allergy symptoms, a simple Spot it, Treat it, Check it approach can help guide the conversation. 1.Spot it …
Children’s Claratyne: clarity in kids’ hayfever
Allergic rhinitis a common condition with pervasive impacts on children. Allergic rhinitis (AR) or hayfever, is common, affecting up to 40% of children.1 AR and asthma commonly coexist, with AR …
Cyventine, the new, nicotine-free, pharmacist only smoking cessation therapy
Cyventine (cytisine) is the first new chemical entity registered in Australia to help adults (aged 18 to 65 years) quit smoking in almost two decades.1* Like varenicline, cytisine is a …